BAKER BROS. ADVISORS LP → BELLICUM PHARMACEUTICALS, INC

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

47 filings by this filer

46 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by BAKER BROS. ADVISORS LP

Filed	Form	Issuer	Stake	Shares
2024-10-08	SC	Kiniksa Pharmaceuticals International, plc KNSA	—	—	view →
2023-10-05	SC	MADRIGAL PHARMACEUTICALS, INC. MDGL	—	—	view →
2022-07-20	SC	Immunocore Holdings plc IMCR	—	—	view →
2022-02-14	SC	INCYTE CORP INCY	—	—	view →
2022-02-10	SC	Aeglea BioTherapeutics, Inc. SYRE	—	—	view →
2021-10-01	SC	Kodiak Sciences Inc. KOD	—	—	view →
2021-07-26	SC	Kodiak Sciences Inc. KOD	—	—	view →
2021-05-18	SC	Seagen Inc.	—	—	view →
2021-05-18	SC	INCYTE CORP INCY	—	—	view →
2021-04-02	SC	Talis Biomedical Corp	—	—	view →
2021-03-19	SC	Aeglea BioTherapeutics, Inc. SYRE	—	—	view →
2021-03-05	SC	Kodiak Sciences Inc. KOD	—	—	view →
2021-01-05	SC	IGM Biosciences, Inc.	—	—	view →
2020-12-11	SC	IGM Biosciences, Inc.	—	—	view →
2020-11-24	SC	Kodiak Sciences Inc. KOD	—	—	view →
2020-09-08	SC	Kodiak Sciences Inc. KOD	—	—	view →
2020-07-28	SC	Kiniksa Pharmaceuticals, Ltd. KNSA	—	—	view →
2020-07-17	SC	BeiGene, Ltd. BEIGF	—	—	view →
2020-05-19	SC	SEATTLE GENETICS INC /WA	—	—	view →
2020-05-18	SC	Kiniksa Pharmaceuticals, Ltd. KNSA	—	—	view →

Showing 20 of 46

BAKER BROS. ADVISORS LP → BELLICUM PHARMACEUTICALS, INC

Item 4 — Purpose of Transaction

Cross-References

Other Filings by BAKER BROS. ADVISORS LP

Want this depth on every filing the moment it hits SEC EDGAR?